Pre-Conference Workshop Day

Pre-Conference Day

Tuesday 4th April 2023

8:00 am Registration Opens & Morning Coffee

8:50 am Chair’s Opening Remarks

Workshop A

9:00 am Discussing the Newest Advancements in Administering Vaccines


Advances in vaccine engineering are soaring, particularly within the investigation of the novel route of administration. The COVID pandemic revealed the necessity for effective and rapid treatments with vaccines. This session will consider the latest advances in novel routes of administration, from nasal, ocular, dermal, and beyond. Join this session to discuss:

• The latest advancements with novel routes of administration beyond the ‘classic’ subcutaneous injector

• Intranasal vaccines as the way forward for future pandemics

• Necessity for an updated route of administration and ways it may affect patient treatment

11:00 am Morning Break & Speed Networking

Workshop B

12:00 pm The Next-Generation of Therapeutics: mRNA Therapeutics Using Computational Modeling


Computational Modeling has a very broad and sweeping impact in many areas. It allows us to see new and increasingly powerful ways of understanding genomics, immunology, and more. This exciting technology is accelerating and reshaping vaccine design. In this session, we will discuss how AI computational Modeling is particularly valuable to the design of mRNA vaccines, especially in R&D. Join this session to discuss:

• Ways AI will have a pervasive impact on the development of vaccines going forward

• The role of AI in the field of clinical trials for vaccines treating infectious diseases

• How did AI contribute to the design of COVID vaccines

14:00 pm Networking Lunch

Workshop C

3:00 pm Exploring the Future for RSV Prevention & Treatment

  • Judith Alamares-Sapuay Biotherapeutics Manager, Sanofi Pasteur
  • Simon van Haren Principal Investigator, Precision Vaccines Program, Boston Children's Hospital, Children's Hospital Boston


Respiratory syncytial virus (RSV) not only infects nearly all infants but is also a massive burden for older adults. Before the COVID pandemic, RSV had predictable seasonality in temperate regions, with numbers peaking in the winter months. In this session, we will consider the implications of the changes to RSV transmission for future prevention strategies. Join this session to discuss:

• The latest advancements in RSV Vaccines

• Ways COVID has changed RSV and what we can do about it

• The race to produce the optimal RSV vaccine for both adults and children

17:00 pm End of Pre-Conference Workshop Day